-
Duke University Mesothelioma Study Yields Surprising News
Immediately after a patient’s mesothelioma is diagnosed, physicians work to come up with the most effective treatment approach. Many patients are treated using a multi-modality protocol that includes a combination of chemotherapy, radiation therapy and surgery, though the order of delivery is highly dependent upon the patient’s specific condition. It is not unusual for surgeons
-
Research Shows Upsides and Downsides of Mesothelioma Clinical Trial Participation
One of the first things that a patient diagnosed with malignant mesothelioma may consider is whether or not to participate in one of the many clinical trials being conducted by major research centers and teaching hospitals. These trials each have their own specific criteria for participation, and those who do choose to get involved do
-
Hopkins Study Details Impact of Financial Stress on Mesothelioma Patients
The stress of a mesothelioma diagnosis is nearly unbearable. The condition, which is caused by exposure to asbestos, is always considered fatal, and the treatments that can prolong survival time are disruptive and come with side effects. They are also extremely costly and insurance rarely pays for all of it. Now a study out of
-
Greater Understanding of Risk Guides Use of Opioids in Mesothelioma Patients
Malignant mesothelioma is diagnosed in approximately 3,000 Americans every year, and those patients’ treatment protocols are guided by the type of mesothelioma they have, how far advanced their disease is, their overall health, their age, and other factors. Most follow a multimodality path of radiation therapy, chemotherapy and surgery, and those that have surgery are
-
Mesothelioma Organization Joins With Other Patient Groups Impacted by Coronavirus
The coronavirus pandemic has impacted the entire world, and one of the lesser-known effects is the one being felt by organizations that support those suffering from malignant mesothelioma and other health conditions. To counter this, the heads of 213 patient and community-based organizations have collectively written to the leaders of Congress, imploring them to include
-
The Latest Developments in Mesothelioma Research
Though malignant mesothelioma remains one of the most challenging types of cancer, there are tremendous breakthroughs being made in research every day, and each one brings us closer to more effective treatments and an eventual cure. Among the most promising of these is inquiry into the tumor microenvironment or TME. This scientific term describes the
-
Expert Witness Points to Talc Used By Hairdressers As Overlooked Source of Mesothelioma
Anybody who is familiar with malignant mesothelioma knows that there are certain occupations that have a high level of association with the disease as a result of their known exposure to asbestos. According to a highly respected occupational health physician, those professions — shipyard workers, electricians, insulators, factory workers, firefighters and more — have been
-
Study Concludes That Exposure To Cosmetic Talc Can Lead to Mesothelioma
Recent headlines have featured the stories of mesothelioma victims filing successful lawsuits against Johnson & Johnson and other cosmetic talc product companies, holding them responsible for their terminal diagnoses. The stories of these victims have raised fears among countless people who’ve used talc-based products throughout the years. Now a new study published in the American Journal
-
Retired Penn State Professor’s Family Sues University After His Mesothelioma Death
Nearly six years after retired Penn State University professor Peter Labosky Jr. died of malignant mesothelioma, his family’s lawsuit against the school is making its way through Pennsylvania’s courts. The case is notable both because it is the first filed against a university by a former employee, and because it was made possible by a 2013
-
What People With Mesothelioma Need to Know About COVID-19
If you have been diagnosed with malignant mesothelioma and are being treated with chemotherapy, radiation therapy, or other advanced protocols, these treatments and the disease itself likely put you in the category of people who are immunocompromised. This puts you at far greater risk when it comes to the effects of COVID-19. Here is what
-
Mesothelioma Lawsuit Reveals Lack of Oversight From Talc Product Company
At the heart of every mesothelioma lawsuit is the question of whether the asbestos product company being sued was negligent or reckless. That issue was on full display this week as a New Jersey jury heard an executive from the company that sold Clubman talcum powder admit that the company had never bothered to conduct
-
Mesothelioma Conference Impacted by Coronavirus Fears
As concerns about the coronavirus pandemic spread around the world, its impact is being felt within the community of mesothelioma patients and researchers alike. As medical professionals take measures to protect already vulnerable patients from exposure to those who may unknowingly carry the virus, researchers working towards a cure for the rare and fatal form
-
Jury Awards Elderly Woman $9 Million in Johnson & Johnson’s Baby Powder Mesothelioma Lawsuit
Johnson & Johnson continues to defend itself against accusations of causing malignant mesothelioma, but the company has increasingly seen juries deciding against it and awarding significant juries to victims who claim that asbestos their talc-based powders caused their illness. The most recent verdict was handed down by a Florida jury that awarded 82-year-old Blanca Moure-Cabrera
-
Talc Mesothelioma Lawsuits Extend to Revlon Over Popular Body Powder
The talc mesothelioma lawsuits that have been capturing the public’s attention have largely centered around claims against Johnson & Johnson over their popular baby powder product. But a recent case filed in New York state court has evoked yet another familiar brand name, as a husband and wife blame Revlon’s Jean Nate talcum powder products
-
Study of Women With Mesothelioma Links Disease With History of Exposure to Asbestos Worker
The cause of malignant mesothelioma has long been known: the rare and fatal form of cancer is caused by exposure to asbestos. But few studies have specifically looked at women diagnosed with the condition, and where their exposure came from. Now a study published in the American Journal of Surgical Pathology has demonstrated that most
-
Italian Study Provides Valuable Insights on Peritoneal Mesothelioma Risk
There are many types of cancer that, like malignant mesothelioma, are caused by exposure to some type of carcinogenic material. Benzene exposure can lead to leukemia; BPA exposure can lead to breast cancer; and obviously, nicotine and tobacco products can lead to lung cancer. In most cases, the more time has elapsed since last exposure,
-
Asbestos In MTA Bus Depot Raises Mesothelioma Fears for Employees and Students
In the long list of occupations that put people at risk for malignant mesothelioma, you’d be hard pressed to find public transit bus employee. Yet there are thousands of New York transit employees who recently learned that they were subjected to decades of asbestos exposure at New York MTA’s East New York bus depot in
-
Thai Asbestos Study Reveals The Relentless Risk of Mesothelioma
It’s long been known that asbestos is a carcinogenic material, and that it has caused countless deaths from malignant mesothelioma, as well as other serious illnesses including asbestosis and asbestos-related lung cancer. While efforts have been made internationally to reduce the use of the mineral, a recent study conducted in Thailand revealed just how difficult
-
Facing 1,700 Mesothelioma Deaths in 50 Years, Colombia Readies for Asbestos Ban
Facing increasing pressure and the harsh reality of tragic mesothelioma and asbestos-related disease deaths in their country, the government of Colombia instituted a full ban on all use of asbestos. The battle had been waged for twelve years when the Latin American country’s House of Representatives voted unanimously to stop asbestos use, mining and export.
-
New Mesothelioma Drug Option To Become Available in 2022
In a notable development for patients diagnosed with unresectable malignant mesothelioma, the U.S. Food and Drug Administration has given its approval for a new version of the chemotherapy drug pemetrexed to be used in the treatment of the rare and fatal form of cancer. Pemetrexed, which is sold under the brand name Alimta and manufactured
